ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,586, issued on March 17, was assigned to DUKE UNIVERSITY (Durham, N.C.).

"Cross-species compatible adeno-associated virus compositions and methods of use thereof" was invented by Aravind Asokan (Durham, N.C.), Trevor Gonzalez (Durham, N.C.) and Lawrence Patrick Havlik (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides adeno-associated virus (AAV) vectors, comprising coevolved capsid variant proteins, pharmaceutical compositions, methods of making, and methods for delivering such to a subject."

The patent was filed on May 5, 2021, under Application No. 17/922,962.

*For further information, including images...